{"name":"Fenproporex","slug":"fenproporex","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Femproporex","Fenorex","J268.797f","3-[(1-phenylpropan-2-yl)amino]propanenitrile","Fenproporexum","3-((1-phenylpropan-2-yl)amino)propanenitrile","239-772-0","240-444-4","Desobesi","DEA No. 1575"],"brands":[],"scraped":true,"has_structure":true,"cid":61810,"classes":[{"name":"prodrug","href":"/class/prodrug"},{"name":"stimulant","href":"/class/stimulant"}],"families":[{"name":"amphetamine","href":"/substituted/amphetamine"}],"physical":[{"label":"Molecular mass","value":"188.27 g/mol","copyable":false},{"label":"Melting point","value":"146","copyable":false},{"label":"Predicted LogP","value":"1.9","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>12</sub>H<sub>16</sub>N<sub>2</sub>","copyable":true},{"label":"IUPAC name","value":"3-(1-phenylpropan-2-ylamino)propanenitrile","copyable":true},{"label":"SMILES","value":"CC(CC1=CC=CC=C1)NCCC#N","copyable":true},{"label":"InChI","value":"InChI=1S/C12H16N2/c1-11(14-9-5-8-13)10-12-6-3-2-4-7-12/h2-4,6-7,11,14H,5,9-10H2,1H3","copyable":true},{"label":"InChIKey","value":"IQUFSXIQAFPIMR-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"16397-28-7","copyable":true},{"label":"UNII","value":"W0194S5FOA","copyable":true},{"label":"PubChem CID","value":"61810","copyable":true}],"pharmacokinetics":[{"label":"Metabolism","value":"Partly converted to amphetamine (30–60%)<a href=\"#cite_note-3\"><sup>[3]</sup></a>","copyable":false},{"label":"Excretion","value":"Urine, mainly as amphetamine, about 5 to 9% unchanged","copyable":false},{"label":"Routes of administration","value":"By mouth","copyable":false}],"toxicity":[],"dosing":null,"salts":[{"title":"Fenproporex hydrochloride","name":"hydrochloride","slug":"fenproporex_hydrochloride","drawn":true}],"esters":[],"chirality":"racemic","stereo_type":"enantiomer","optical_activity":"( + / - )","stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[],"mesh":[],"actives":[{"name":"Amphetamine","href":"/substance/amphetamine"}],"prodrugs":[],"codrug":false,"interactions":[],"mechanism":"Fenproporex is an amphetamine based anorectic which is rapidly metabolized into amphetamine in the body. Both acute and chronic fenproporex administration has been shown to increase brain energy metabolism in young rats, by increasing the activity of citrate synthase, malate dehydrogenase, succinate dehydrogenase, creatine kinase and complexes I,II, III, and IV. [8]  Amphetamine based drugs are also known to reduce food intake. They are addictive substances due to their ability to increase dopamine release, however their anorectic effects are believed to be a result of noradrenergic neurotransmission. Activation of the alpha 1 and beta 2 adrenoceptors has been shown to decrease food intake, and drugs which release norepinephrine or block norepinephrine reuptake can activate these receptors. [3]   The alpha 1 and beta 2 adrenoceptors are noted to be clinically important receptors in weight regulation. [3]","side_effects":null,"effects":{"groups":[["Physical Effects",["Abnormal heartbeat","Appetite suppression","Dehydration","Dry mouth","Increased blood pressure","Increased heart rate","Increased libido","Restless legs","Shakiness","Stamina enhancement","Stimulation","Teeth grinding","Vasoconstriction"]],["Cognitive Effects",["Analysis enhancement","Cognitive euphoria","Compulsive redosing","Disinhibition","Ego inflation","Focus enhancement","Increased music appreciation","Mania","Motivation enhancement","Suggestibility suppression","Thought acceleration","Wakefulness"]]]},"usernotes":[],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Brazil","status":"B2","act":null,"refs":[4]},{"jurisdiction":"Canada","status":"Schedule IV","act":null,"refs":[]},{"jurisdiction":"United States","status":"Schedule IV","act":"Controlled Substances Act","refs":[]},{"jurisdiction":"Germany","status":"Prescription only/Anlage III","act":null,"refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Fenproporex"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/61810"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q5443577"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB01550"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL2105566"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A134837"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=16397-28-7"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0252218"},{"source":"KEGG","url":"https://www.kegg.jp/entry/D07947"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID0043921"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Fenproporex"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/W0194S5FOA"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 61810, Fenproporex. Accessed November 21, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/61810>https://pubchem.ncbi.nlm.nih.gov/compound/61810</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Fenproporex. UNII: W0194S5FOA. Global Substance Registration System. Accessed November 21, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/W0194S5FOA>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/W0194S5FOA</a>","Seyffart G. Drug dosage in renal insufficiency. Springer. 1991. <a href='https://books.google.com/books?id=FubgMz6aOWAC'>https://books.google.com/books?id=FubgMz6aOWAC</a>","RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. <a href='https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992'>https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 09:59:47","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 09:59:42","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 09:59:43","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 09:59:44","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 09:59:42","note":"hmdb.ca refused automated access to HMDB0252218"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 09:59:44","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 09:59:41","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 09:59:43","note":"no r/tripreports posts mention it"},{"source":"sider","status":"missing","fetched_at":"2026-11-20 09:59:42","note":"not in SIDER"},{"source":"structure","status":"ok","fetched_at":"2026-11-20 09:59:42","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 09:59:43","note":null}],"description":"Fenproporex is a prodrug, stimulant substance."}